CATALOG
ITALIAN WEBSITES
Domain and Website Information:
permax.it
About site:
Domain name - permax.it
Site title - Permax – Forniture per laboratori scientifici
Go to website - Permax – Forniture per laboratori scientifici
Words count at permax.it:
laboratori - 7
permax - 7
prodotti - 7
strumentazione - 6
linea - 6
scientifici - 5
vetro - 5
scopri - 5
migliore - 4
See complete list
Site GEO location
Location Country - Italy
Provider - Server Plan S.r.l.
Site Logo
There is no Open Graph data at permax.it
Information for domain permax.it
IP address:
Domain name servers:
ns1.nomeasy.com ns2.nomeasy.com
All records:
☆ permax.it. 600 IN A 77.39.212.161
☆ permax.it. 3600 IN MX 0 permax-it.mail.protection.outlook.com.
☆ permax.it. 21600 IN SOA ns1.nomeasy.com. postmaster.permax.it. 2023112816 14400 3600 1209600 86400
☆ permax.it. 21600 IN NS ns2.nomeasy.com.
☆ permax.it. 21600 IN NS ns1.nomeasy.com.
☆ permax.it. 3600 IN TXT "v=spf1 include:spf.protection.outlook.com include:turbo-smtp.com -all"
☆ permax.it. 3600 IN TXT "MS=ms81706921"
Whois server information for permax.it
Brief facts about permax:
Pergolide, sold under the brand name Permax and Prascend among others, is an ergoline-based dopamine receptor agonist used in some countries for the treatment of Parkinson's disease. Parkinson's disease is associated with reduced dopamine activity in the substantia nigra of the brain. Pergolide acts on many of the same receptors as dopamine to increase receptor activity. It was patented in 1978 and approved for medical use in 1989. In 2007, pergolide was withdrawn from the U.S. market for human use after several published studies revealed a link between the drug and increased rates of valvular heart disease. However, a veterinary form of pergolide, marketed under the trade name Prascend, is permitted for the treatment of pituitary pars intermedia dysfunction also known as equine Cushing's syndrome in horses.
© DMS 2011-